Skip to main content
. 2021 Aug 10;112(10):3979–3994. doi: 10.1111/cas.15059

TABLE 1.

Inflammasome‐mediated pyroptosis promotes tumor development

Stimulation factor Pyroptotic signaling Pro‐inflammatory cytokines Normal cells Cancer cells Reference
NLRP3‐mediated IL‐1β Head and neck squamous cell Head and neck squamous cell carcinoma (31)
Alcohol Caspase‐1‐mediated IL‐1β and IL‐18 Esophagus Esophagus cancer (32)
Caspase‐1‐dependent IL‐1β and IL‐18 Barrett's esophagus Esophagus cancer (33)
GSDMD‐mediate IL‐1β Lung Non‑small‐cell lung cancer (34)
Helicobacter pylori NLRP3‐mediate IL‐1β and IL‐18 Stomach Gastric cancer (35)
Caspase‐1‐mediate Hepatocyte Human hepatocellular carcinoma (36)
Hepatitis C virus NLRP3‐mediate Hepatocyte Human hepatocellular carcinoma (37)
Caspase‐1‐mediate Pancreas Pancreatic ductal adenocarcinoma (38)
Caspase‐1‐mediate IL‐1β Melanoma Melanoma (39)
NLRP3‐mediate IL‐1β Breast cell Breast cancer (40)
IL‐1β Breast cell Breast cancer (41)
Caspase‐1‐mediate IL‐1 Human cutaneous squamous cell Human cutaneous squamous cell carcinoma (42)
High‐risk human papillomaviruses IL‐1β Anogenital Anogenital cancer (43)

The activation of inflammasome could trigger caspase‐1‐mediated pyroptosis and promote tumor development.